Volume-Based Procurement in Mainland China: Key Trends and Planning Future Strategies

Volume-based Procurement in Mainland China: Key trends and planning future strategies Reforms will allow Mainland China to achieve its objective of high quality and affordable healthcare for its citizens Robust access and reimbursement environment Uniform pricing across the nation High quality and certified generic drugs of international standard Elimination of bureaucracy and corruption Increasing push for innovation in Mainland China Rising focus on high performing off-patent molecules Success of GQCE and VBP - benchmarks for future national access and reimbursement reforms Less expensive drugs for patients and lower healthcare costs for the government ‣ Clarivate™ 6

View entire presentation